Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective

Brett MacFarlane1,2 1Australian College of Pharmacy, Canberra, ACT, Australia; 2Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia Abstract: Gastroesophageal reflux disease (GERD) is a common gastrointestinal diagnosis, a leading reason for endoscopy and cause of potent...

Full description

Bibliographic Details
Main Author: MacFarlane B
Format: Article
Language:English
Published: Dove Medical Press 2018-06-01
Series:Integrated Pharmacy Research and Practice
Subjects:
Online Access:https://www.dovepress.com/management-of-gastroesophageal-reflux-disease-in-adults-a-pharmacists--peer-reviewed-article-IPRP
_version_ 1819266323014746112
author MacFarlane B
author_facet MacFarlane B
author_sort MacFarlane B
collection DOAJ
description Brett MacFarlane1,2 1Australian College of Pharmacy, Canberra, ACT, Australia; 2Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia Abstract: Gastroesophageal reflux disease (GERD) is a common gastrointestinal diagnosis, a leading reason for endoscopy and cause of potentially serious complications, resulting in significant individual and system-wide health burden. Approximately one quarter of people living in western countries have experienced GERD, and the prevalence appears to be on the rise. Risk factors for GERD include hiatus hernia, obesity, high-fat diet, tobacco smoking, alcohol consumption, pregnancy, genetics, and some medications. The cardinal symptoms of GERD are troublesome heartburn and regurgitation. GERD is identified by taking a patient-centered history and if necessary can be classified by endoscopic investigation. The role of the pharmacist in the management of GERD is to confirm the diagnosis by history taking, confirm there are no alarming signs or symptoms that require referral to a doctor, and recommendation of short-term therapy to control symptoms. Effective pharmacological treatments for GERD include antacids, alginate, histamine H2 receptor antagonists, and proton pump inhibitors. This narrative review includes a comparison of the efficacy and safety of these treatments and pertinent information to help pharmacists advise patients with GERD on their appropriate use. Keywords: GERD, GORD, reflux, pharmacist, PPI
first_indexed 2024-12-23T20:59:26Z
format Article
id doaj.art-fcd163a3103a4e54951d5089281d496c
institution Directory Open Access Journal
issn 2230-5254
language English
last_indexed 2024-12-23T20:59:26Z
publishDate 2018-06-01
publisher Dove Medical Press
record_format Article
series Integrated Pharmacy Research and Practice
spelling doaj.art-fcd163a3103a4e54951d5089281d496c2022-12-21T17:31:26ZengDove Medical PressIntegrated Pharmacy Research and Practice2230-52542018-06-01Volume 7415238665Management of gastroesophageal reflux disease in adults: a pharmacist’s perspectiveMacFarlane BBrett MacFarlane1,2 1Australian College of Pharmacy, Canberra, ACT, Australia; 2Faculty of Health, Queensland University of Technology, Brisbane, QLD, Australia Abstract: Gastroesophageal reflux disease (GERD) is a common gastrointestinal diagnosis, a leading reason for endoscopy and cause of potentially serious complications, resulting in significant individual and system-wide health burden. Approximately one quarter of people living in western countries have experienced GERD, and the prevalence appears to be on the rise. Risk factors for GERD include hiatus hernia, obesity, high-fat diet, tobacco smoking, alcohol consumption, pregnancy, genetics, and some medications. The cardinal symptoms of GERD are troublesome heartburn and regurgitation. GERD is identified by taking a patient-centered history and if necessary can be classified by endoscopic investigation. The role of the pharmacist in the management of GERD is to confirm the diagnosis by history taking, confirm there are no alarming signs or symptoms that require referral to a doctor, and recommendation of short-term therapy to control symptoms. Effective pharmacological treatments for GERD include antacids, alginate, histamine H2 receptor antagonists, and proton pump inhibitors. This narrative review includes a comparison of the efficacy and safety of these treatments and pertinent information to help pharmacists advise patients with GERD on their appropriate use. Keywords: GERD, GORD, reflux, pharmacist, PPIhttps://www.dovepress.com/management-of-gastroesophageal-reflux-disease-in-adults-a-pharmacists--peer-reviewed-article-IPRPGERDGORDrefluxpharmacistPPI
spellingShingle MacFarlane B
Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective
Integrated Pharmacy Research and Practice
GERD
GORD
reflux
pharmacist
PPI
title Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective
title_full Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective
title_fullStr Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective
title_full_unstemmed Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective
title_short Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective
title_sort management of gastroesophageal reflux disease in adults a pharmacist rsquo s perspective
topic GERD
GORD
reflux
pharmacist
PPI
url https://www.dovepress.com/management-of-gastroesophageal-reflux-disease-in-adults-a-pharmacists--peer-reviewed-article-IPRP
work_keys_str_mv AT macfarlaneb managementofgastroesophagealrefluxdiseaseinadultsapharmacistrsquosperspective